Efflux-Enhanced Imidazoquinolines To Exploit Chemoresistance

Efflux-Enhanced Imidazoquinolines To Exploit Chemoresistance

Saved in:

Bibliographic Details
Main Authors:	Muhammad Haroon, Sharmin Sultana, Seyedeh A. Najibi, Emily T. Wang, Abbey Michaelson, Pranto S. M. Al Muied, Amy E. Nielsen, Rock J. Mancini
Format:	Article
Language:	English
Published:	American Chemical Society 2025-03-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.4c11297
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Performance of Imidazoquinoline Glycoconjugate BAIT628 as a TLR7 Agonist Prodrug for Prostate Cancer
by: Seyedeh A. Najibi, et al.
Published: (2025-05-01)

Recent progress in the synthesis of imidazoquinoline derivatives
by: Warda Jahangir, et al.
Published: (2025-05-01)

Cus efflux system and resistance to nanoparticles.
by: Khanal, P.
Published: (2020-08-01)

The role of TLR-4 in chemoresistance of cancer
by: Yuhua Li, et al.
Published: (2025-05-01)

Suppressing an auxin efflux transporter enhances rice adaptation to temperate habitats
by: Yanchun Cui, et al.
Published: (2025-05-01)

Determination of chemoresistance of ovarian cancer cells in vitro
by: K. A. Kuzin, et al.
Published: (2019-12-01)

Warburg effect and lactylation in cancer: mechanisms for chemoresistance
by: Wenjie Zhang, et al.
Published: (2025-04-01)

PHGDH drives 5-FU chemoresistance in colorectal cancer through the Hedgehog signaling
by: Caterina Mancini, et al.
Published: (2025-07-01)

Targeting CSC-immune cell crosstalk to overcome chemoresistance and enhance immunotherapy efficacy
by: Guanxiao Yu, et al.
Published: (2025-07-01)

Epigenetic Drivers of Chemoresistance in Nucleobase and Nucleoside Analog Therapies
by: John Kaszycki, et al.
Published: (2025-07-01)

Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
by: Wang Caixia, et al.
Published: (2025-01-01)

Chemoresistance factors in non-small cell lung cancer
by: А. I. Shevchenko, et al.
Published: (2016-04-01)

Exploiting Exploitation Cinema: an Introduction
by: David Roche
Published: (2016-07-01)

Evaluation of Some Efflux Pump Genes in Pseudomonas aeruginosa and their Relation to Antibiotic Resistance
by: Roaa Abd Al-rahman Abdulla, et al.
Published: (2024-10-01)

Establishment of a chemoresistant laryngeal cancer cell model to study chemoresistance and chemosensitization responses via transcriptomic analysis and a tumor‐on‐a‐chip platform
by: Christian R. Moya‐Garcia, et al.
Published: (2025-05-01)

Structural basis of siderophore export and drug efflux by Mycobacterium tuberculosis
by: Jennifer C. Earp, et al.
Published: (2025-02-01)

Xenon for tunnelling analysis of the efflux pump component OprN.
by: Yvette Véronique Ntsogo Enguéné, et al.
Published: (2017-01-01)

Study the Role of the Efflux Pump in Multidrug-Resistant Acinetobacter baumannii
by: Nazhad Hassan Mohammed, et al.
Published: (2023-04-01)

Signaling networks and MiRNA crosstalk in ovarian cancer chemoresistance
by: Raksha Nayak, et al.
Published: (2025-08-01)

SPL-108 mitigates metastasis and chemoresistance in tubo-ovarian carcinoma
by: Olivia D. Lara, et al.
Published: (2025-01-01)

OXPHOS inhibition overcomes chemoresistance in triple negative breast cancer
by: Cemile Uslu, et al.
Published: (2025-06-01)

Naturally derived efflux pump inhibitor among tetracycline-resistant Acinetobacter baumannii isolates
by: Ruqaya Kareem Abass Al-ammery, et al.
Published: (2024-01-01)

The AcrAB efflux pump contributes to the virulence of Enteroaggregative E. coli by influencing the aggregative behavior
by: Martina Laudazzi, et al.
Published: (2025-08-01)

Luteolin Nanomedicine with Stimulus-Driven Traceless Release for Targeting Treatment of Atherosclerosis by Enhancing Lipid Efflux
by: Songzan Chen, et al.
Published: (2025-01-01)

6-gingerol enhances ciprofloxacin efficacy by inhibiting NorA efflux pump in Staphylococcus aureus
by: Shashikanta Sau, et al.
Published: (2025-06-01)

Efflux Pumps and Porins Enhance Bacterial Tolerance to Phenolic Compounds by Inhibiting Hydroxyl Radical Generation
by: Xinyue Sui, et al.
Published: (2025-01-01)

Heterogeneous efflux pump expression underpins phenotypic resistance to antimicrobial peptides
by: Ka Kiu Lee, et al.
Published: (2025-07-01)

Specificity and tunability of efflux pumps: A new role for the proton gradient?
by: Matthew Gerry, et al.
Published: (2025-01-01)

Multidrug efflux pumps of Pseudomonas aeruginosa show selectivity for their natural substrates
by: Léna Mazza, et al.
Published: (2025-01-01)

Influence of Bioluminescence Imaging Dynamics by D-Luciferin Uptake and Efflux Mechanisms
by: Yimao Zhang, et al.
Published: (2012-11-01)

A K+-Efflux Antiporter is Vital for Tolerance to Salt Stress in Rice
by: Wei Xie, et al.
Published: (2025-06-01)

Molecular characterization of efflux pumps in beta-lactam resistant pseudomonas aeruginosa
by: Elmira Shah Cheraghi, et al.
Published: (2024-11-01)

Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
by: Weijia Li, et al.
Published: (2023-01-01)

Factors of chemoresistant pulmonary tuberculosis progression in patients receiving palliative treatment
by: O. M. Raznatovska, et al.
Published: (2018-06-01)

PHD1 regulates p53‐mediated colorectal cancer chemoresistance
by: Sofie Deschoemaeker, et al.
Published: (2015-08-01)

Large-scale CRISPRi screens link metabolic stress to glioblastoma chemoresistance
by: Xing Li, et al.
Published: (2025-03-01)

Exosome-Mediated Chemoresistance in Cancers: Mechanisms, Therapeutic Implications, and Future Directions
by: Gengqi Liu, et al.
Published: (2025-05-01)

Overcoming chemoresistance in mucinous adenocarcinoma: the impact of tumor microenvironment and genetic alterations
by: Kaniga Pandi, et al.
Published: (2025-06-01)

The interplay between COX-2, chemotherapeutic drugs, and chemoresistance in colon cancer
by: Sally M. Shalaby, et al.
Published: (2025-05-01)

Chemoresistance of PRAME-expressing melanoma cell can be resolved with help of bortezomib
by: V. A. Misyurin, et al.
Published: (2019-01-01)